Overview


According to FutureWise analysis, the market for MR Vaccines is expected to grow with a CAGR of 2.1% over the forecast period 2024-2032, and reach a market value of US$ 6.15 Million by 2031. 

The Measles and Rubella (MR) vaccine is a combined immunization designed to confer protection against two highly contagious viruses: measles and rubella. These viruses, belonging to the genus Morbillivirus (measles) and Rubivirus (rubella), respectively, have the potential to cause widespread outbreaks and serious health complications if left uncontrolled. The MR vaccine is a triumph of modern medicine, formulated through careful attenuation or inactivation of the live viruses to induce an immune response without causing the actual diseases. It primarily consists of weakened measles and rubella viruses or, in some formulations, inactivated versions of these viruses.

Upon administration, the immune system recognizes these weakened or inactivated viruses as foreign invaders. This triggers a robust immune response, producing specific antibodies targeted against the measles and rubella viruses. These antibodies serve as the body's "memory" of the viruses, enabling it to mount a rapid and effective defense if it encounters the pathogens in the future. The MR vaccine is typically administered in two doses, usually in combination with the mumps vaccine as the MMR vaccine. The first dose is given around the age of one, while the second dose is administered at a slightly older age, often before a child starts school. This two-dose regimen ensures optimal and long-lasting immunity against both measles and rubella.

FutureWise Market Research has published a report that provides an insightful analysis of MR Vaccines Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the MR Vaccines Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • PT Bio Farma
  • Bio-Manguinhos
  • BE Vaccines
  •  Serum Institute of India
  • Crucell Switzerland AG.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Major drivers for the market include strong support and funding from governments worldwide for immunization programs targeting measles and rubella. These programs aim to achieve high vaccination coverage and prevent outbreaks. International initiatives and commitments to eliminate measles and rubella globally, such as the Measles & Rubella Initiative and the Global Vaccine Action Plan, drive demand for MR vaccines, particularly in regions with high disease burden. Public awareness campaigns conducted by health organizations play a crucial role in educating communities about the importance of MR vaccination, leading to increased vaccine demand. Rising birth rates and a larger pediatric population contribute to increased demand for childhood vaccines, including MR vaccines, as they are typically administered during early childhood. Improvements in healthcare infrastructure, particularly in developing regions, lead to increased accessibility to vaccines. This facilitates broader vaccine coverage, including MR vaccines, and bolsters the market.

However, vaccine hesitancy, fueled by misinformation and misconceptions about vaccine safety and efficacy, can hinder the acceptance and uptake of MR vaccines, leading to lower vaccination rates. Ensuring vaccines are stored and transported at appropriate temperatures and reach remote or underserved areas can be logistically complex, especially in regions with limited healthcare infrastructure, hindering market growth.

By Vaccine Brand

  • MR Vaccine
  • MRBEV (BE LTD.)

By Distribution Channel

  • Public
  • Private

By Region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022 due to the rise in demand for vaccines, robust healthcare infrastructure, the prominent presence of key industry players, and heightened research endeavours in this geographical region. In addition, the government raising funds for the welfare of society, raising awareness about the vaccine, and organizing vaccine camps are driving the market.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the MR Vaccines Market By Vaccine Brand, By Distribution Channel and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction

    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology

    •   1. Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3. Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary

    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  MR Vaccines Market Variables, Trends & Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview

    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of MR Vaccines Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  MR Vaccines Market Analysis Tools

    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  MR Vaccines Market, By Vaccine Brand Historical Analysis and Forecast 2024-2032 (USD Million)

    •   1. MR Vaccine
        2. MRBEV (BE LTD.)

  • 8.  MR Vaccines Market, By Distribution Channel Historical Analysis and Forecast 2024-2032 (USD Million)

    •   1. Public
        2. Private

  • 9.  North America MR Vaccines Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 10.  Latin America MR Vaccines Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 11.  Europe MR Vaccines Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 12.  Asia Pacific MR Vaccines Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

  • 13.  Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 14.  Market Share Analysis and Competitive Landscape

    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 15.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. PT Bio Farma
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. Bio-Manguinhos
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. BE Vaccines
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. Serum Institute of India,
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5. Crucell Switzerland AG
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. SWOT Analysis
           5.4. Financial Overview
           5.5. Strategic Overview

  • 16.  Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.  FutureWise SME Key Takeaway Points for Client

    •     


Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11